Total Payments
$14,647
2024 Payments
$42.66
Companies
56
Transactions
941
Medicare Patients
1,434
Medicare Billing
$137,140
Payment Breakdown by Category
Food & Beverage$14,636 (99.9%)
Education$11.71 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,636 | 940 | 99.9% |
| Education | $11.71 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,776 | 115 | $0 (2022) |
| Amgen Inc. | $1,644 | 78 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,340 | 83 | $0 (2022) |
| ABBVIE INC. | $891.46 | 51 | $0 (2024) |
| PFIZER INC. | $824.26 | 66 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $786.40 | 52 | $0 (2022) |
| Lilly USA, LLC | $785.23 | 49 | $0 (2023) |
| Allergan, Inc. | $687.90 | 73 | $0 (2020) |
| GlaxoSmithKline, LLC. | $660.57 | 52 | $0 (2022) |
| Amarin Pharma Inc. | $492.52 | 28 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42.66 | 2 | ABBVIE INC. ($42.66) |
| 2023 | $173.43 | 4 | EAGLE PHARMACEUTICALS, INC. ($124.98) |
| 2022 | $1,679 | 90 | Amgen Inc. ($334.74) |
| 2021 | $2,682 | 143 | Amgen Inc. ($429.04) |
| 2020 | $2,471 | 152 | AstraZeneca Pharmaceuticals LP ($287.69) |
| 2019 | $2,375 | 178 | AstraZeneca Pharmaceuticals LP ($282.69) |
| 2018 | $2,604 | 184 | Novo Nordisk Inc ($255.38) |
| 2017 | $2,622 | 188 | Novo Nordisk Inc ($371.73) |
All Payment Transactions
941 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiology | ||||||
| 05/04/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiology | ||||||
| 03/29/2023 | EAGLE PHARMACEUTICALS, INC. | BARHEMSYS (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Post Operative Nausea and Vomiting | ||||||
| 01/17/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Diabetes | ||||||
| 12/07/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: Cardiology | ||||||
| 11/30/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/21/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Inflammation | ||||||
| 10/16/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 09/28/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: PRIMARY CARE | ||||||
| 09/27/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/08/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: Neuroscience | ||||||
| 09/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2022 | ABBVIE INC. | LINZESS (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: Diabetes | ||||||
| 08/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: Diabetes | ||||||
| 08/19/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.09 | General |
| 08/16/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Diabetes | ||||||
| 08/11/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.73 | General |
| 08/09/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Diabetes | ||||||
| 08/05/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 335 | 426 | $47,697 | $36,572 |
| 2021 | 10 | 572 | 746 | $71,300 | $53,361 |
| 2020 | 12 | 527 | 675 | $70,393 | $47,207 |
Total Patients
1,434
Total Services
1,847
Medicare Billing
$137,140
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 251 | $31,046 | $20,735 | 66.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $13,027 | $13,108 | 100.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $2,309 | $2,120 | 91.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 51 | 51 | $975.12 | $492.30 | 50.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 13 | 13 | $339.82 | $117.86 | 34.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 175 | 345 | $42,610 | $27,380 | 64.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 123 | 123 | $16,315 | $16,315 | 100.0% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 54 | 54 | $2,160 | $2,160 | 100.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $3,128 | $2,093 | 66.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 11 | 11 | $2,436 | $1,915 | 78.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 29 | 29 | $1,872 | $1,872 | 100.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 76 | 78 | $1,670 | $812.51 | 48.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 29 | 29 | $715.00 | $509.53 | 71.3% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 14 | 16 | $393.54 | $303.04 | 77.0% |
| 91300 | Sarscov2 vac 30mcg/0.3ml im | Office | 2021 | 44 | 44 | $0.44 | $0.44 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 161 | 297 | $36,461 | $20,897 | 57.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 116 | 116 | $15,181 | $13,817 | 91.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 23 | 23 | $4,322 | $2,505 | 58.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 14 | 14 | $2,746 | $2,394 | 87.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 20 | $3,291 | $2,060 | 62.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 22 | 22 | $1,342 | $1,342 | 100.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 37 | $3,084 | $1,259 | 40.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 11 | 11 | $1,267 | $1,247 | 98.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 81 | 84 | $1,606 | $923.49 | 57.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 27 | 27 | $571.05 | $463.32 | 81.1% |
About Dr. Karen Baerenstecher, M.D
Dr. Karen Baerenstecher, M.D is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659592574.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karen Baerenstecher, M.D has received a total of $14,647 in payments from pharmaceutical and medical device companies, with $42.66 received in 2024. These payments were reported across 941 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($14,636).
As a Medicare-enrolled provider, Baerenstecher has provided services to 1,434 Medicare beneficiaries, totaling 1,847 services with total Medicare billing of $137,140. Data is available for 3 years (2020–2022), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Houston, TX
- Active Since 05/01/2007
- Last Updated 05/09/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659592574
Products in Payments
- Ozempic (Drug) $963.27
- FARXIGA (Drug) $821.25
- Livalo (Drug) $786.40
- Aimovig (Biological) $557.29
- XIFAXAN (Drug) $537.17
- Vascepa (Drug) $492.52
- JARDIANCE (Drug) $491.51
- TRULICITY (Drug) $422.83
- EVENITY (Biological) $399.83
- Saxenda (Drug) $379.66
- LINZESS (Drug) $355.18
- JANUVIA (Drug) $319.19
- XARELTO (Drug) $286.98
- TRELEGY ELLIPTA (Drug) $280.91
- Synthroid (Drug) $264.71
- Repatha (Biological) $250.48
- UBRELVY (Drug) $242.12
- Prolia (Biological) $223.86
- Otezla (Drug) $212.83
- Trintellix (Drug) $207.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Internal Medicine $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Internal Medicine $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
Internal Medicine $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947
Internal Medicine $786,947